Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/2012
02/23/2012US20120046185 Panel of biomarkers for ovarian cancer
02/23/2012US20120046182 Neoepitope detection of disease using protein arrays
02/23/2012US20120045851 Labels, their production process and their uses
02/23/2012US20120045848 Pyrenyloxysulfonic acid fluorescent agents
02/23/2012US20120045816 Novel Glycosylated Polypeptides
02/23/2012US20120045782 Imatinib immunoassay
02/23/2012US20120045780 Signal biomarkers
02/23/2012US20120045779 Method for diagnosing endometriosis and diagnostic kit for endometriosis
02/23/2012US20120045777 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
02/23/2012US20120045776 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof
02/23/2012US20120045775 Phosphospecific pak antibodies and diagnostic kits
02/23/2012US20120045774 Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy
02/23/2012US20120045773 Cell adhesion inhibitor and applications thereof
02/23/2012US20120045763 Antibodies Against Cells of Fetal Origin
02/23/2012US20120045755 Her-2 binding antagonists
02/23/2012US20120045467 Influenza virus vaccine composition and methods of use
02/23/2012US20120045465 Cancer antigen helper peptide
02/23/2012US20120045457 Nontypable haemophilus influenzae antigens
02/23/2012US20120045456 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations
02/23/2012US20120045453 Anti-IL-6 Antibodies, Compositions, Methods and Uses
02/23/2012US20120045447 T cell costimulating polypeptides and uses thereof
02/23/2012US20120045446 Therapeutic agent for diseases in which neoplastic proliferation of plasma cells occurs
02/23/2012US20120045445 Method of treating viral diseases
02/23/2012US20120045443 Agonist anti-trk-c monoclonal antibodies
02/23/2012US20120045442 Human monoclonal antibodies to ctla-4
02/23/2012US20120045439 Tumor markers and methods of use thereof
02/23/2012US20120045438 Engineered anti-il-13 antibodies, compositions, methods and uses
02/23/2012US20120045437 MONOCLONAL ANTIBODIES THAT INHIBIT THE Wnt SIGNALING PATHWAY AND METHODS OF PRODUCTION AND USE THEREOF
02/23/2012US20120045432 B lymphocyte stimulator assays
02/23/2012US20120045429 Methods and Agent for Modulating the RNA Polymerase II-Histone Surface
02/23/2012US20120045394 Human and mouse targeting peptides identified by phage display
02/23/2012US20120045391 Formulations Targeting IGFBP7 for Diagnosis and Therapy of Cancer
02/23/2012US20120045390 Composition and Methods for the Diagnosis and Treatment of Tumor
02/23/2012DE102006043625B4 Verfahren zur Isolierung und/oder Identifizierung von mesenchymalen Stammzellen (MSC) A method for isolating and / or identifying mesenchymal stem cells (MSC)
02/23/2012CA2808744A1 Combined use of fc gamma riib (cd32b) and cd20 specific antibodies
02/23/2012CA2808683A1 Improved anti-serum albumin binding variants
02/23/2012CA2808577A1 Anti-ngf antibodies and their use
02/23/2012CA2808482A1 Methods for the generation of multispecific and multivalent antibodies
02/23/2012CA2808382A1 Antibodies that bind myostatin, compositions and methods
02/23/2012CA2808361A1 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
02/23/2012CA2808211A1 Combination therapy with anti-cd74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases
02/23/2012CA2808187A1 Amyloid-beta binding proteins
02/23/2012CA2807617A1 Elution of proteins from hydroxyapatite resins without resin deterioration
02/23/2012CA2807243A1 Combination therapy of an afucosylated cd20 antibody with an anti-vegf antibody
02/23/2012CA2807227A1 Improved antibodies of the class igg4
02/23/2012CA2806851A1 Anti-human igg1 antibody
02/23/2012CA2806637A1 Antibodies for epidermal growth factor receptor 3 (her3)
02/23/2012CA2805176A1 Humanized anti-interleukin 3 receptor alpha chain antibodies
02/22/2012EP2420576A2 Use of HE4 and other biochemical markers for assessment of ovarian cancers
02/22/2012EP2420572A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
02/22/2012EP2420516A1 Rapid generation of T cell-independent antibody responses to T cell-dependent antigens
02/22/2012EP2420515A1 Diagnosis and treatment of cancer using anti-tmprss11e antibody
02/22/2012EP2420514A1 Targeted binding agents directed to PDGFR-alpha and uses thereof
02/22/2012EP2420513A1 Targeted binding agents directed to PDGFR-alpha and uses thereof
02/22/2012EP2420512A2 Anti-VEGF antibodies
02/22/2012EP2420252A1 EPHB3-specific antibody and uses thereof
02/22/2012EP2420251A2 Ligands that enhance endogenous compounds
02/22/2012EP2420250A1 Anti-Syndecan-4 antibodies
02/22/2012EP2420248A1 Mutated HIV NEF for modulating immunity
02/22/2012EP2420246A1 Methods and compositions based on shiga toxin type 1 protein
02/22/2012EP2419452A1 Affinity material
02/22/2012EP2419451A1 Antibodies against prostate specific membrane antigen
02/22/2012EP2419450A1 USE OF TRIFUNCTIONAL BISPECIFIC ANTIBODIES FOR THE TREATMENT OF TUMORS ASSOCIATED WITH CD133+/EpCAM+CANCER STEM CELLS
02/22/2012EP2419449A1 B-lymphocyte targeting agents for use in a method for the treatment of a disease
02/22/2012EP2419448A1 Anti-tnf- antibodies and their uses
02/22/2012EP2419447A1 Antibodies that specifically bind to a beta oligomers and use thereof
02/22/2012EP2419446A2 Humanized antibody compositions and methods for binding lysophosphatidic acid
02/22/2012EP2419445A2 New methods of making an antibody and compositions thereof
02/22/2012EP2419444A1 Therapeutic antennapedia-antibody molecules and methods of use thereof
02/22/2012EP2419134A1 Treatment of inflammatory diseases by inhibiting cold- inducible rna-binding protein (cirp)
02/22/2012EP2419133A1 Rspondin-3 inhibition in bone disorders
02/22/2012EP2361988A9 Molecular marker for cancer stem cell
02/22/2012EP2134841B1 Methods for producing active scfv antibodies and libraries therefor
02/22/2012EP1708752B1 Polymer-bound antibody cancer therapeutic agent
02/22/2012EP1697746B1 Risk markers for cardiovascular disease
02/22/2012EP1691836B1 Anti-pecam therapy for metastasis suppression
02/22/2012EP1255555B1 NON-MAMMALIAN GnRH ANALOG AND USES THEREOF IN REGULATING FERTILITY AND PREGNANCY
02/22/2012CN1913921B 通过靶定暴露在细胞凋亡肿瘤细胞上的内部抗原杀死肿瘤细胞的方法 By targeting the apoptotic expose internal antigens of tumor cells to kill tumor cells of the
02/22/2012CN1642976B 一种突变的免疫球蛋白-结合蛋白 A mutant immunoglobulin - binding protein
02/22/2012CN102361977A Nucleic acid derived from hepatitis c virus, and expression vector, transformed cell and hepatitis c virus particles each prepared by using same
02/22/2012CN102361884A Bispecific anti-erbb-2/anti-c-met antibodies
02/22/2012CN102361883A Bispecific anti-erbb-1/anti-c-met antibodies
02/22/2012CN102360015A Anti-alzheimer's disease monoclonal antibody and application thereof
02/22/2012CN102358903A Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
02/22/2012CN102358895A Monoclonal antibody mcf2 and application thereof
02/22/2012CN102358754A Protein from RHBDD1 and use thereof in preparing monoclonal antibody for detecting colon and rectal cancer or breast cancer
02/22/2012CN102358751A Human fibrinogen-like protein 2 prothrombinase immunogenicity peptide and use thereof
02/22/2012CN101362802B Dna依赖蛋白激酶催化亚基单链抗体及其编码基因与应用 Dna-dependent protein kinase catalytic subunit of single-chain antibody and its coding gene and application
02/22/2012CN101027084B 用于调节免疫的突变型hiv nef Mutant hiv nef for regulating immunity
02/21/2012US8120791 Image synthesizing apparatus
02/21/2012US8119787 Molecular tools for manufacturing anti-CD33 antibodies and fragments
02/21/2012US8119775 Human anti-KIR antibodies
02/21/2012US8119774 Cell marker for hepatic and pancreatic stem cells and progenitor cells
02/21/2012US8119590 Apolipoprotein A-I (ApoA-I), preferably a variant form such as Apolipoprotein A-I Milano (ApoA-IM), alone or more preferably in combination with a lipid carrier such as phospholipids or other drug, can be administered locally
02/21/2012US8119340 Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemia
02/21/2012US8119138 Anti-estrogen and immune modulator combinations for treating breast cancer
02/21/2012US8119132 Humanized anti-tag-72 monoclonal antibodies
02/21/2012US8119131 IL-17 antagonistic antibodies
02/21/2012US8119130 Targeted binding agents directed to KDR and uses thereof—035
02/21/2012US8119127 Cytokine antagonists for neurological and neuropsychiatric disorders
1 ... 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 ... 1494